Published in Virology on July 20, 2000
Herpes simplex virus type 1 DNA polymerase requires the mammalian chaperone hsp90 for proper localization to the nucleus. J Virol (2005) 1.40
Inhibition of human cytomegalovirus DNA polymerase by C-terminal peptides from the UL54 subunit. J Virol (2003) 1.01
Nuclear transport of Epstein-Barr virus DNA polymerase is dependent on the BMRF1 polymerase processivity factor and molecular chaperone Hsp90. J Virol (2013) 0.87
Regulated transport into the nucleus of herpesviridae DNA replication core proteins. Viruses (2013) 0.78
The Pseudorabies Virus DNA Polymerase Accessory Subunit UL42 Directs Nuclear Transport of the Holoenzyme. Front Microbiol (2016) 0.76
Acute skin eruptions that are positive for herpes simplex virus DNA polymerase in patients with stem cell transplantation: a new manifestation within the erythema multiforme reactive dermatoses. Arch Dermatol (2008) 0.75
Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci U S A (1993) 11.85
Physical mapping of herpes simplex virus-induced polypeptides. J Virol (1978) 6.08
Control of protein synthesis in herpesvirus-infected cells: analysis of the polypeptides induced by wild type and sixteen temperature-sensitive mutants of HSV strain 17. J Gen Virol (1976) 5.47
Recombinants between herpes simplex virus types 1 and 2: analyses of genome structures and expression of immediate early polypeptides. J Virol (1978) 4.87
Herpes simplex virus proteins: DNA-binding proteins in infected cells and in the virus structure. Virology (1975) 3.41
The 65,000-Mr DNA-binding and virion trans-inducing proteins of herpes simplex virus type 1. J Virol (1987) 2.63
Genetic and biochemical studies with herpesvirus. Cold Spring Harb Symp Quant Biol (1975) 2.47
Characterization of the 92,000-dalton glycoprotein induced by herpes simplex virus type 2. J Virol (1984) 2.36
American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive summary of recommendations. J Endocrinol Invest (2010) 2.20
Low pH activates the vacuolating toxin of Helicobacter pylori, which becomes acid and pepsin resistant. J Biol Chem (1995) 2.17
Purification of the herpes simplex virus type 1 65-kilodalton DNA-binding protein: properties of the protein and evidence of its association with the virus-encoded DNA polymerase. J Virol (1988) 2.14
Identification of the herpes simplex virus protein kinase as the product of viral gene US3. J Gen Virol (1987) 2.06
The m2 form of the Helicobacter pylori cytotoxin has cell type-specific vacuolating activity. Proc Natl Acad Sci U S A (1998) 1.95
Formation of anion-selective channels in the cell plasma membrane by the toxin VacA of Helicobacter pylori is required for its biological activity. EMBO J (1999) 1.88
AME position statement on adrenal incidentaloma. Eur J Endocrinol (2011) 1.82
Identification of the gene encoding the 65-kilodalton DNA-binding protein of herpes simplex virus type 1. J Virol (1988) 1.81
Helicobacter pylori cytotoxin: importance of native conformation for induction of neutralizing antibodies. Infect Immun (1995) 1.79
A three-nucleotide deletion in the UL97 open reading frame is responsible for the ganciclovir resistance of a human cytomegalovirus clinical isolate. J Virol (1995) 1.71
Aloe-emodin is a new type of anticancer agent with selective activity against neuroectodermal tumors. Cancer Res (2000) 1.71
Circulating endothelial progenitor cells in subjects with erectile dysfunction. Int J Impot Res (2005) 1.65
The product of gene US11 of herpes simplex virus type 1 is expressed as a true late gene. J Gen Virol (1986) 1.63
Processing of herpes simplex virus proteins and evidence that translation of thymidine kinase mRNA is initiated at three separate AUG codons. J Virol (1983) 1.62
Two-dimensional gel analysis of HSV type 1-induced polypeptides and glycoprotein processing. J Gen Virol (1981) 1.61
Helicobacter pylori toxin VacA induces vacuole formation by acting in the cell cytosol. Mol Microbiol (1997) 1.60
Bacterial protein toxins penetrate cells via a four-step mechanism. FEBS Lett (1994) 1.58
A potential role for the vanilloid receptor TRPV1 in the therapeutic effect of curcumin in dinitrobenzene sulphonic acid-induced colitis in mice. Neurogastroenterol Motil (2007) 1.56
Temperature-sensitive mutants of herpes simplex virus differ in the capacity to establish latent infections in mice. Virology (1977) 1.54
The 10K virion phosphoprotein encoded by gene US9 from herpes simplex virus type 1. Virology (1986) 1.50
Ribonucleotide reductase encoded by herpes simplex virus is a determinant of the pathogenicity of the virus in mice and a valid antiviral target. J Gen Virol (1988) 1.49
Identification of the Helicobacter pylori VacA toxin domain active in the cell cytosol. Infect Immun (1998) 1.48
Utilization of internal AUG codons for initiation of protein synthesis directed by mRNAs from normal and mutant genes encoding herpes simplex virus-specified thymidine kinase. J Virol (1985) 1.47
The herpes simplex virus type 1 origin-binding protein interacts specifically with the viral UL8 protein. J Gen Virol (1994) 1.45
Human cytomegalovirus and restenosis of the internal carotid artery. Stroke (1996) 1.43
Cytospray fixation of frozen intraoperative sections. Mod Pathol (1999) 1.42
Involvement of recA and exr genes in the in vivo inhibition of the recBC nuclease. J Bacteriol (1974) 1.42
Specific inhibition of herpesvirus ribonucleotide reductase by synthetic peptides. Nature (1986) 1.42
The products of gene US11 of herpes simplex virus type 1 are DNA-binding and localize to the nucleoli of infected cells. J Gen Virol (1987) 1.41
Sulphated glycoproteins induced by herpes simplex virus. J Gen Virol (1982) 1.40
American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: Executive Summary of recommendations. J Endocrinol Invest (2010) 1.40
American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. J Endocrinol Invest (2010) 1.39
Early and rapid diagnosis of CMV infection by nonradioactive in situ hybridization in pediatric kidney transplant recipients. Nephron (1992) 1.39
Thyroid nodules: a review of current guidelines, practices, and prospects. Eur J Endocrinol (2008) 1.39
Effect of helicobacter pylori vacuolating toxin on maturation and extracellular release of procathepsin D and on epidermal growth factor degradation. J Biol Chem (1997) 1.38
The ribonucleotide reductase induced by herpes simplex virus type 1 involves minimally a complex of two polypeptides (136K and 38K). J Gen Virol (1985) 1.36
Peptidyl anthraquinones as potential antineoplastic drugs: synthesis, DNA binding, redox cycling, and biological activity. J Med Chem (1996) 1.29
Localization on the herpes simplex virus type 1 genome of a region encoding proteins involved in adsorption to the cellular receptor. J Virol (1990) 1.26
Identification of two herpes simplex virus type 1-induced proteins (21K and 22K) which interact specifically with the a sequence of herpes simplex virus DNA. J Gen Virol (1984) 1.26
Helicobacter pylori vacuolating toxin forms anion-selective channels in planar lipid bilayers: possible implications for the mechanism of cellular vacuolation. Biophys J (1999) 1.22
Monoclonal antibodies to the C4 region of human immunodeficiency virus type 1 gp120: use in topological analysis of a CD4 binding site. AIDS Res Hum Retroviruses (1992) 1.20
Staphylococcal alpha-toxin: a study of membrane penetration and pore formation. J Biol Chem (1989) 1.20
Lipid interaction of the 37-kDa and 58-kDa fragments of the Helicobacter pylori cytotoxin. Eur J Biochem (1995) 1.19
Acute infection of differentiated neuroblastoma cells by latency-positive and latency-negative herpes simplex virus ts mutants. Virology (1979) 1.18
Towards deciphering the Helicobacter pylori cytotoxin. Mol Microbiol (1999) 1.18
West Nile virus transmission with human cases in Italy, August - September 2009. Euro Surveill (2009) 1.18
3D imaging of the 58 kDa cell binding subunit of the Helicobacter pylori cytotoxin. J Mol Biol (1999) 1.16
Genomic location and lack of phosphorylation of the HSV immediate-early polypeptide IE 12. J Gen Virol (1982) 1.14
One functional copy of the long terminal repeat gene specifying the immediate-early polypeptide IE 110 suffices for a productive infection of human foetal lung cells by herpes simplex virus. J Gen Virol (1981) 1.08
Low-activity (2.0 GBq; 54 mCi) radioiodine post-surgical remnant ablation in thyroid cancer: comparison between hormone withdrawal and use of rhTSH in low-risk patients. Eur J Endocrinol (2008) 1.07
The transmissible spongiform encephalopathies: emerging and declining epidemics. Biochem Soc Trans (2006) 1.06
Novel herpes simplex virus type 1 glycoproteins identified by antiserum against a synthetic oligopeptide from the predicted product of gene US4. J Gen Virol (1986) 1.05
Role of multivesicular bodies and their components in the egress of enveloped RNA viruses. Rev Med Virol (2009) 1.04
Separation methods for acyclovir and related antiviral compounds. J Chromatogr B Biomed Sci Appl (2001) 1.04
Genome sequence analysis of the first human West Nile virus isolated in Italy in 2009. Euro Surveill (2009) 1.03
Intranuclear delivery of an antiviral peptide mediated by the B subunit of Escherichia coli heat-labile enterotoxin. Proc Natl Acad Sci U S A (1999) 1.03
Independence with respect to Ca2+ changes of the neutrophil respiratory and secretory response to exogenous phospholipase C and possible involvement of diacylglycerol and protein kinase C. Biochim Biophys Acta (1985) 1.02
The large subunit of herpes simplex virus type 1 ribonucleotide reductase: expression in Escherichia coli and purification. Virology (1991) 1.02
Generation and properties of the glycoprotein E-related 32K/34K/35K and 55K/57K polypeptides encoded by herpes simplex virus type 1. J Gen Virol (1987) 1.01
Helicobacter pylori VacA cytotoxin associated with the bacteria increases epithelial permeability independently of its vacuolating activity. Microbiology (1999) 1.00
Severe thyrotoxicosis due to hyperfunctioning liver metastasis from follicular carcinoma: treatment with (131)I and interstitial laser ablation. Thyroid (1999) 1.00
Maternal antibodies to gp120 V3 sequence do not correlate with protection against vertical transmission of human immunodeficiency virus. J Infect Dis (1992) 1.00
Thyroid tissue: US-guided percutaneous interstitial laser ablation-a feasibility study. Radiology (2000) 1.00
Helicobacter pylori neutrophil-activating protein stimulates tissue factor and plasminogen activator inhibitor-2 production by human blood mononuclear cells. J Infect Dis (2001) 0.98
Synthesis and biological evaluation of N6-cycloalkyl derivatives of 1-deazaadenine nucleosides: a new class of anti-human immunodeficiency virus agents. J Med Chem (1995) 0.97
Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up. Minerva Endocrinol (2013) 0.96
On the mechanism of action of quinolone drugs. Trends Microbiol (1993) 0.96
The Helicobacter pylori VacA toxin is a urea permease that promotes urea diffusion across epithelia. J Clin Invest (2001) 0.96
Increased risk of NASH in patients carrying the C(-159)T polymorphism in the CD14 gene promoter region. Gut (2006) 0.96
Ultrasound guided percutaneous ethanol injection in the treatment of cystic thyroid nodules. Clin Endocrinol (Oxf) (1994) 0.95
An intact interchain disulfide bond is required for the neurotoxicity of tetanus toxin. Infect Immun (1990) 0.95
A prospective study of BK-virus-associated haemorrhagic cystitis in paediatric patients undergoing allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant (2007) 0.95
Thyroid nodules treated with percutaneous radiofrequency thermal ablation: a comparative study. J Clin Endocrinol Metab (2012) 0.95
Natural history of gastro-entero-pancreatic and thoracic neuroendocrine tumors. Data from a large prospective and retrospective Italian epidemiological study: the NET management study. J Endocrinol Invest (2011) 0.94
Clinical and virological findings in the ongoing outbreak of West Nile virus Livenza strain in northern Italy, July to September 2012. Euro Surveill (2012) 0.94
HIV coreceptor tropism in paired plasma, peripheral blood mononuclear cell, and cerebrospinal fluid isolates from antiretroviral-naïve subjects. J Clin Microbiol (2011) 0.94
Characterisation of a monoclonal antibody and its use to purify the cytotoxin of Helicobacter pylori. FEMS Microbiol Lett (1998) 0.93
HSV-2 specific seroprevalence among various populations in Rome, Italy. The Italian Herpes Management Forum. Sex Transm Infect (2000) 0.93
Processing of herpes simplex virus type 1 glycoproteins: two-dimensional gel analysis using monoclonal antibodies. J Gen Virol (1983) 0.92
Effects of CD4 synthetic peptides on HIV type I envelope glycoprotein function. J Immunol (1992) 0.92
Active-site mutations of the diphtheria toxin catalytic domain: role of histidine-21 in nicotinamide adenine dinucleotide binding and ADP-ribosylation of elongation factor 2. Biochemistry (1994) 0.92
Viral load in HCV RNA-positive pregnant women. Am J Gastroenterol (2001) 0.92
Urinary JCV-DNA testing during natalizumab treatment may increase accuracy of PML risk stratification. J Neuroimmune Pharmacol (2012) 0.91
The cytotoxic activity of Bacillus anthracis lethal factor is inhibited by leukotriene A4 hydrolase and metallopeptidase inhibitors. Biochem J (1996) 0.91
Molecular and cellular activities of Helicobacter pylori pathogenic factors. FEBS Lett (1999) 0.91
Herpes simplex virus chronically infected human T lymphocytes are susceptible to HIV-1 superinfection and support HIV-1 pseudotyping. J Acquir Immune Defic Syndr (1999) 0.91
Partial purification of the superoxide-generating system of macrophages. Possible association of the NADPH oxidase activity with a low-potential (-247 mV) cytochrome b. Biochim Biophys Acta (1985) 0.91
Diphtheria toxin and its mutant crm 197 differ in their interaction with lipids. FEBS Lett (1987) 0.91
Intracellular localisation of herpes simplex virus type 1 ribonucleotide reductase subunits during infection of cultured cells. Virology (1995) 0.90
The herpes simplex virus type 1 strain 17 open reading frame RL1 encodes a polypeptide of apparent M(r) 37K equivalent to ICP34.5 of herpes simplex virus type 1 strain F. J Gen Virol (1993) 0.90